DRAP
The new article describes in detail the key aspects related to the Pharmacovigilance Risk Assessment Expert Committee (PRAEC).
MDCG
The final article of the cycle highlights the key points related to certain specific product categories, outlining the most important aspects to be taken into consideration.
FDA
The article highlights the key points associated with the regulatory status of dental ceramics, as well as the requirements they should comply with.
ANVISA
The article provides a brief overview of the regulatory requirements applicable to personalised medical devices intended to be marketed and used in Brazil.
EU
The article highlights the key points related to the regulatory status of in vitro diagnostic medical devices under the existing legal framework.
EU
The final article of the cycle is dedicated to combination products and their specific regulatory nature.
